BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10898979)

  • 1. Adhesion to target cells is disrupted by the killer cell inhibitory receptor.
    Burshtyn DN; Shin J; Stebbins C; Long EO
    Curr Biol; 2000 Jun; 10(13):777-80. PubMed ID: 10898979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recruitment of SHP-1 protein tyrosine phosphatase and signalling by a chimeric T-cell receptor-killer inhibitory receptor.
    Christensen MD; Geisler C
    Scand J Immunol; 2000 Jun; 51(6):557-64. PubMed ID: 10849365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killer cell Ig-like receptor-dependent signaling by Ig-like transcript 2 (ILT2/CD85j/LILRB1/LIR-1).
    Kirwan SE; Burshtyn DN
    J Immunol; 2005 Oct; 175(8):5006-15. PubMed ID: 16210603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
    Yusa S; Campbell KS
    J Immunol; 2003 May; 170(9):4539-47. PubMed ID: 12707331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158).
    Long EO; Barber DF; Burshtyn DN; Faure M; Peterson M; Rajagopalan S; Renard V; Sandusky M; Stebbins CC; Wagtmann N; Watzl C
    Immunol Rev; 2001 Jun; 181():223-33. PubMed ID: 11513144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases.
    Gupta N; Scharenberg AM; Burshtyn DN; Wagtmann N; Lioubin MN; Rohrschneider LR; Kinet JP; Long EO
    J Exp Med; 1997 Aug; 186(3):473-8. PubMed ID: 9236201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actin cytoskeleton controls the efficiency of killer Ig-like receptor accumulation at inhibitory NK cell immune synapses.
    Standeven LJ; Carlin LM; Borszcz P; Davis DM; Burshtyn DN
    J Immunol; 2004 Nov; 173(9):5617-25. PubMed ID: 15494512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand binding to inhibitory killer cell Ig-like receptors induce colocalization with Src homology domain 2-containing protein tyrosine phosphatase 1 and interruption of ongoing activation signals.
    Vyas YM; Maniar H; Lyddane CE; Sadelain M; Dupont B
    J Immunol; 2004 Aug; 173(3):1571-8. PubMed ID: 15265884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
    Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
    J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of killer cell inhibitory receptor-mediated signal transduction machinery in a cell-free model system.
    Cho HI; Park CG; Kim J
    Arch Biochem Biophys; 1999 Aug; 368(2):221-31. PubMed ID: 10441372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous clustering and tyrosine phosphorylation of NK cell inhibitory receptor induced by ligand binding.
    Faure M; Barber DF; Takahashi SM; Jin T; Long EO
    J Immunol; 2003 Jun; 170(12):6107-14. PubMed ID: 12794140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation.
    Binstadt BA; Brumbaugh KM; Dick CJ; Scharenberg AM; Williams BL; Colonna M; Lanier LL; Kinet JP; Abraham RT; Leibson PJ
    Immunity; 1996 Dec; 5(6):629-38. PubMed ID: 8986721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cell receptors.
    Lanier LL
    Annu Rev Immunol; 1998; 16():359-93. PubMed ID: 9597134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase.
    Marti F; Xu CW; Selvakumar A; Brent R; Dupont B; King PD
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11810-5. PubMed ID: 9751747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW; Burshtyn DN
    Sci STKE; 2001 Mar; 2001(75):re1. PubMed ID: 11752646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of killer cell inhibitory receptors for MHC class I molecules.
    Vély F; Olcese L; Bléry M; Vivier E
    Immunol Lett; 1996 Dec; 54(2-3):145-50. PubMed ID: 9052869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.